Skip to main content
Clinical Trials/NCT03120416
NCT03120416
Completed
Not Applicable

Effect of Resistance Exercise Training on Endothelial Function and Cardiovascular Risk Factors in Patients With Chronic Kidney Disease

University of Illinois at Chicago1 site in 1 country34 target enrollmentJanuary 25, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Chronic Kidney Disease
Sponsor
University of Illinois at Chicago
Enrollment
34
Locations
1
Primary Endpoint
Endothelial function
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

The investigators aim to evaluate the feasibility of a resistance exercise training program among individuals with CKD and its impact on endothelial and vascular function.

Detailed Description

Resistance exercise training has been shown to improve cardiovascular health including endothelial function in general populations, but studies in patients with chronic kidney disease (CKD) are limited. The investigators aim to evaluate the feasibility and acceptability of a resistance exercise training program among individuals with CKD and its impact on endothelial and vascular function as measured by brachial artery flow-mediated dilation, pulse-wave velocity and carotid artery stiffness. To accomplish this goal the investigators propose to conduct a 12-week pilot randomized controlled trial of twice a week resistance exercise training among 32 adults with CKD. The results of this study will inform the design and implementation of a larger trial evaluating the impact of resistance exercise training on adverse outcomes in patients with CKD including CKD progression.

Registry
clinicaltrials.gov
Start Date
January 25, 2017
End Date
July 31, 2018
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ana C. Ricardo, MD, MPH, MS

Assistant Professor of Medicine

University of Illinois at Chicago

Eligibility Criteria

Inclusion Criteria

  • CKD stage 3 or 4 (eGFR 15-60 ml/min/1.73m2)

Exclusion Criteria

  • Currently institutionalized
  • Kidney transplant or dialysis
  • NY Heart Association class 3-4 heart failure
  • Dementia or cognitive impairment
  • Unstable angina or coronary revascularization within the last 3 months
  • Uncontrolled arrhythmia
  • Severe chronic lung disease
  • Orthopedic, neurologic or other condition that would preclude resistance exercise training
  • Pregnancy
  • Uncontrolled hypertension (systolic \> 160 mmHg and diastolic \>90 mmHg)

Outcomes

Primary Outcomes

Endothelial function

Time Frame: 3 months

Measured by brachial artery flow-mediated dilation (FMD)

Secondary Outcomes

  • Objectively measured physical activity(3 months)
  • Serum LDL-cholesterol(3 months)
  • Vascular function(3 months)
  • Carotid artery stiffness(3 months)
  • Systolic blood pressure(3 months)
  • Muscle strength(3 months)
  • Self-reported physical activity(3 months)
  • Serum HDL-cholesterol(3 months)

Study Sites (1)

Loading locations...

Similar Trials